SCHEMBL5727115

SCHEMBL5727115

CON=C(c1ccccc1)c1ccc2c(c1)sc(=O)n2CCOc1ccc(CC(OC)C(=O)O)cc1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 16/20 0.63
PPARA Q07869 19/20 0.57
PPARD Q03181 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727106 1.00 PPARG (0.63) PPARGPPARAPPARD
SCHEMBL5424349 0.94 PPARG (0.68) PPARGPPARA
SCHEMBL5424352 0.94 PPARG (0.68) PPARGPPARA
SCHEMBL5421831 0.93 PPARA (0.67) PPARGPPARAPPARD
SCHEMBL5727708 0.93 PPARG (0.60) PPARGPPARA
SCHEMBL5429733 0.93 PPARA (0.67) PPARGPPARAPPARD
SCHEMBL5427997 0.93 PPARA (0.67) PPARGPPARAPPARD
SCHEMBL5727704 0.93 PPARG (0.60) PPARGPPARA
SCHEMBL5913743 0.93 PPARG (0.71) PPARGPPARA
SCHEMBL5913737 0.93 PPARG (0.71) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1502590-B1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes SERVIER LAB (FR) 2006-12-20 EP claimed
EP-1502590-A1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes Les Laboratoires Servier (FR) 2005-02-02 EP claimed
EP-1502590-B1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes SERVIER LAB (FR) 2006-12-20 EP disclosed
EP-1729767-A1 COMBINATION OF A HETEROCYCLIC COMPOUND AND AN ANTIOXIDANT AND USE THEREOF FOR TREATING OBESITY Les Laboratoires Servier (FR) 2006-12-13 EP disclosed
WO-2005099694-A1 COMBINATION OF A HETEROCYCLIC COMPOUND AND AN ANTIOXIDANT AND USE THEREOF FOR TREATING OBESITY LES LABORATOIRES SERVIER (FR) 2005-10-27 WO disclosed
EP-1502590-A1 Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type II diabetes Les Laboratoires Servier (FR) 2005-02-02 EP disclosed